General information

Announcements(1)

Program

Sessions

Search presentations

Download PDF for print

Timetable

Mon. Mar 17, 2025

Tue. Mar 18, 2025

Wed. Mar 19, 2025

web_header_en.png

web_icon.png

Profile management

Announcements

Bookmark

Program Type

Login required to view

Password required to view

Presentation Information

Session Details

To browse or post comments, you must log in.

You cannot post comments as it is outside the comment posting period.

This comment has been deleted. You cannot reply to this comment.

Drug therapy for chronic kidney disease

Joint Session : The Japanese Society of Pathophysiology

The purpose of this symposium is to understand the impairment of internal biological systems caused by chronic kidney disease (CKD), which is estimated to affect 200 million individuals worldwide. To this end, speakers are called from various fields – anatomist, physiologist, pharmacologist, and experts in CKD treatment.    There is a definitive difference between severe damage to the kidney and that of other organs such as the heart, lung, and liver. That is, severe damage to organs other than the kidney results in death, while people with severe kidney damage can survive with the help of kidney replacement therapy (dialysis and kidney transplantation).    In such patients who have CKD (moderate to severe kidney damage), which is characterized by the accumulation of “uremic" substances, the internal biological system is impaired. Understanding this impairment can be useful from the point of view of aging science, for one of the important aspects of aging is loss of kidney function.

The impairment of internal biological systems caused by chronic kidney disease

APPW2025

Presentation Information

[2S13m-5]Drug therapy for chronic kidney disease

Login required to view

Comment